middle.news
Avecho Secures $1.66M to Power Pivotal CBD Insomnia Drug Trial
1:29am on Monday 2nd of June, 2025 AEST
•
Biotechnology
Read Story
Avecho Secures $1.66M to Power Pivotal CBD Insomnia Drug Trial
1:29am on Monday 2nd of June, 2025 AEST
Key Points
Received $1.66 million R&D tax incentive for 2024
Funds to repay $1.04 million to Endpoint Capital
Supports ongoing Phase III clinical trial for CBD insomnia capsule
Advances commercialisation strategy for pharmaceutical registration
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Avecho Biotechnology (ASX:AVE)
OPEN ARTICLE